These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7552485

  • 41. Incidence of HTLV-I/II infection in seronegative high-risk individuals.
    Al B, Visser S, van den Hoek A, van Doornum G, Coutinho R, Huisman H.
    J Med Virol; 1993 Mar; 39(3):260-5. PubMed ID: 8468567
    [Abstract] [Full Text] [Related]

  • 42. Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India.
    Babu PG, Ishida T, Nesadoss J, John TJ.
    Scand J Infect Dis; 1995 Mar; 27(2):105-8. PubMed ID: 7660071
    [Abstract] [Full Text] [Related]

  • 43. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR, Yan YS, Zhang QW, Zheng J, Liu JM, Feng YY, Wu SQ, Wu JH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [Abstract] [Full Text] [Related]

  • 44. HTLV type I and HTLV type II infection among Indians and natives from Argentina.
    Bouzas MB, Zapiola I, Quiruelas S, Gorvein D, Panzita A, Rey J, Carnese FP, Corral R, Perez C, Zala C.
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1567-71. PubMed ID: 7888211
    [Abstract] [Full Text] [Related]

  • 45. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 46. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM, Remesar M, del Pozo A, Sen L.
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [Abstract] [Full Text] [Related]

  • 47. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients.
    Ramirez E, Fernandez J, Cartier L, Villota C, Rios M.
    Virus Res; 2003 Feb; 91(2):231-9. PubMed ID: 12573502
    [Abstract] [Full Text] [Related]

  • 48. Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama.
    Vitek CR, Gracia FI, Giusti R, Fukuda K, Green DB, Castillo LC, Armien B, Khabbaz RF, Levine PH, Kaplan JE.
    J Infect Dis; 1995 Apr; 171(4):1022-6. PubMed ID: 7706781
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Laboratory study of HIV-1 and HTLV-I/II coinfection.
    Beilke MA, Greenspan DL, Impey A, Thompson J, Didier PJ.
    J Med Virol; 1994 Oct; 44(2):132-43. PubMed ID: 7852953
    [Abstract] [Full Text] [Related]

  • 51. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY, Lim AH, Park JY, Han SH, Cho NS.
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [Abstract] [Full Text] [Related]

  • 52. Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.
    Miyamoto K, Nakamura T, Nagataki S, Tomita N, Kitajima K.
    Jpn J Cancer Res; 1992 May; 83(5):415-7. PubMed ID: 1618692
    [Abstract] [Full Text] [Related]

  • 53. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S.
    Ann Neurol; 1993 Apr; 33(4):392-6. PubMed ID: 8489210
    [Abstract] [Full Text] [Related]

  • 54. Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/HTLV-II): report of 3 cases from Panama.
    Castillo LC, Gracia F, Román GC, Levine P, Reeves WC, Kaplan J.
    Acta Neurol Scand; 2000 Jun; 101(6):405-12. PubMed ID: 10877159
    [Abstract] [Full Text] [Related]

  • 55. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
    Olaleye DO, Ekweozor CC, Sheng Z, Rasheed S.
    Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
    [Abstract] [Full Text] [Related]

  • 56. Neurological aspects of HIV/human T lymphotropic virus coinfection.
    Tulius Silva M, de Melo Espíndola O, Bezerra Leite AC, Araújo A.
    AIDS Rev; 2009 Feb; 11(2):71-8. PubMed ID: 19529747
    [Abstract] [Full Text] [Related]

  • 57. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1988 Dec 09; 37(48):736-40, 745-7. PubMed ID: 3143058
    [No Abstract] [Full Text] [Related]

  • 58. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991 Dec 09; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 59. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S, Krook A, Käll K, Julander I, Thorstensson R, Biberfeld G.
    Scand J Infect Dis; 1995 Dec 09; 27(6):547-50. PubMed ID: 8685631
    [Abstract] [Full Text] [Related]

  • 60. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen IS, Lefrère JJ.
    J Infect Dis; 1992 Feb 09; 165(2):369-72. PubMed ID: 1730903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.